BlackRock
COYA icon

BlackRock’s Coya Therapeutics COYA Stock Holding History

BlackRock’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$326K Buy
82,769
+3,623
+5% +$16.9K ﹤0.01% 4630
2025
Q4 		$459K Buy
79,146
+9,188
+13% +$55.9K ﹤0.01% 4503
2025
Q3 		$399K Buy
69,958
+1,702
+2% +$10.4K ﹤0.01% 4518
2025
Q2 		$392K Sell
68,256
-15,539
-19% -$90K ﹤0.01% 4504
2025
Q1 		$542K Buy
83,795
+7,602
+10% +$48.1K ﹤0.01% 4377
2024
Q4 		$437K Buy
76,193
+10,367
+16% +$70.6K ﹤0.01% 4443
2024
Q3 		$425K Buy
65,826
+1,248
+2% +$7.87K ﹤0.01% 4370
2024
Q2 		$391K Buy
64,578
+10,581
+20% +$85K ﹤0.01% 4406
2024
Q1 		$536K Buy
53,997
+32,222
+148% +$252K ﹤0.01% 4357
2023
Q4 		$161K Sell
21,775
-244
-1% -$1.35K ﹤0.01% 4692
2023
Q3 		$84.6K Buy
22,019
+14,586
+196% +$58K ﹤0.01% 4895
2023
Q2 		$30.3K Sell
7,433
-294
-4% -$1.36K ﹤0.01% 5150
2023
Q1 		$30.7K Buy
+7,727
New +$33.8K ﹤0.01% 5194

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

BlackRock's COYA Position: Q1 2026 in Review

BlackRock increased its Coya Therapeutics (COYA) stake by 4.6% in Q1 2026, buying an estimated $16.9K and bringing the position to 82,769 shares worth $326K. The position accounts for ﹤0.01% of the portfolio, ranked #4630.

BlackRock first reported a position in COYA in Q1 2023 and has held it in 13 quarters since. The position peaked at $542K in Q1 2025. 56 funds tracked by Wall St. Rank hold COYA as of Q1 2026.

  • BlackRock held 82,769 shares of Coya Therapeutics worth $326K as of Q1 2026.
  • BlackRock bought 3,623 Coya Therapeutics shares in Q1 2026, an estimated $16.9K.
  • Coya Therapeutics made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #4630 holding.
  • BlackRock first reported a position in Coya Therapeutics in Q1 2023 and has held it in 13 quarters since.
  • BlackRock's Coya Therapeutics position peaked at $542K in Q1 2025.
  • 56 funds tracked by Wall St. Rank held Coya Therapeutics as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.